Skip to content

Clinical trials

Phase 1/2 Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 1/2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20181
20201
20211
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Unknown status2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fundación Neumologica Colombiana1
Guy's and St Thomas' NHS Foundation Trust1
Janette Furuzawa Carballeda1
Lassen Therapeutics 1 PTY LTD1
Martin Huellner1
National Heart, Lung, and Blood Institute (NHLBI)1
National Human Genome Research Institute (NHGRI)1
Paul Szabolcs1
Peking Union Medical College Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis9
COVID-192
Liver Cirrhosis2
Albinism1
Albinism, Oculocutaneous1
Anemia, Aplastic1
Breast Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Transitional Cell1
Cardiomyopathy, Hypertrophic1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.